IL-6 drives chemoimmunotherapy resistance in NSCLC by reprogramming myeloid cells and impairing cytotoxic lymphocyte function

Cancer Letters 2026

View at publisher

Authors: Yaning Yang, Chengming Liu, Lu Yang, Sufei Zheng, Haiyan Xu, Shuyang Zhang, Linyan Tian, Nan Sun, Jie He, Yan Wang

DOI: 10.1016/j.canlet.2026.218259

Cited by: 2

References: 40

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Immune cells in cancer Lung Cancer Research Studies

References 40